Teachers Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History

Teachers Advisors’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$880K	Buy	68,446 +11,503	+20%	+$130K	﹤0.01%	2347
2018 Q4	$541K	Buy	56,943 +5,021	+10%	+$65.1K	﹤0.01%	2475
2018 Q3	$862K	Sell	51,922 -473	-0.9%	-$7.58K	﹤0.01%	2383
2018 Q2	$841K	Buy	52,395 +8,998	+21%	+$161K	﹤0.01%	2424
2018 Q1	$664K	Hold	43,397	–	–	﹤0.01%	2399
2017 Q4	$677K	Hold	43,397	–	–	﹤0.01%	2427
2017 Q3	$482K	Hold	43,397	–	–	﹤0.01%	2600
2017 Q2	$399K	Buy	43,397 +541	+1%	+$4.51K	﹤0.01%	2707
2017 Q1	$366K	Buy	42,856 +7,661	+22%	+$69.8K	﹤0.01%	2679
2016 Q4	$377K	Buy	35,195 +8,282	+31%	+$100K	﹤0.01%	2680
2016 Q3	$291K	Buy	26,913 +4,060	+18%	+$33K	﹤0.01%	2728
2016 Q2	$155K	Hold	22,853	–	–	﹤0.01%	2976
2016 Q1	$106K	Hold	22,853	–	–	﹤0.01%	2933
2015 Q4	$144K	Hold	22,853	–	–	﹤0.01%	2958
2015 Q3	$202K	Hold	22,853	–	–	﹤0.01%	2877
2015 Q2	$269K	Buy	22,853 +898	+4%	+$12.5K	﹤0.01%	2881
2015 Q1	$318K	Buy	21,955 +5,503	+33%	+$84.2K	﹤0.01%	2696
2014 Q4	$281K	Hold	16,452	–	–	﹤0.01%	2752
2014 Q3	$205K	Hold	16,452	–	–	﹤0.01%	2873
2014 Q2	$241K	Buy	16,452 +1,168	+8%	+$17.9K	﹤0.01%	2846
2014 Q1	$311K	Buy	15,284 +2,520	+20%	+$61.1K	﹤0.01%	2655
2013 Q4	$250K	Hold	12,764	–	–	﹤0.01%	2751
2013 Q3	$578K	Buy	12,764 +752	+6%	+$24.5K	﹤0.01%	2233
2013 Q2	$286K	Buy	+12,012	New	+$191K	﹤0.01%	2567

Other funds holding STML

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Teachers Advisors's STML Position: Q1 2019 in Review

Teachers Advisors increased its Stemline Therapeutics, Inc. (STML) stake by 20% in Q1 2019, buying an estimated $130K and bringing the position to 68,446 shares worth $880K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

Teachers Advisors first reported a position in STML in Q2 2013 and has held it in 24 quarters since. 98 funds tracked by Wall St. Rank hold STML as of Q1 2019.

Teachers Advisors held 68,446 shares of Stemline Therapeutics, Inc. worth $880K as of Q1 2019.
Teachers Advisors bought 11,503 Stemline Therapeutics, Inc. shares in Q1 2019, an estimated $130K.
Stemline Therapeutics, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2347 holding.
Teachers Advisors first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and has held it in 24 quarters since.
98 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.